Remission of Type 2 Diabetes With Lifestyle Intervention
NCT07017127
Summary
The goal of this clinical trial is to achieve diabetes type 2 (DM2) remission using intensive lifestyle intervention. The main questions it aims to answer are: * Does intensive lifestyle intervention (including Mediterranean diet with a caloric deficit, daily physical activity, increase in stress resilience and group support) lead to DM2 remission (HbA1c\<6.5%, without medications) * Can intensive lifestyle intervention (including Mediterranean diet with a caloric deficit, daily physical activity, increase in stress resilience and group support) result to weight loss of \>15 kg * Does intensive lifestyle intervention result in any side effects (secondary outcome) Researchers will compare intensive lifestyle intervention to the usual clinical care (control group). Participants in the experimental group will: * eat Mediterranean diet with a caloric deficit * perform daily physical activity * increase their stress resilience with psychosocial support of the group * enroll weekly in individual and group counseling and workshops for 6 months, following with 1.5 years of follow-up
Eligibility
Inclusion Criteria: * type 2 diabetes diagnosis * incident cases or diagnosed not more than 7 years ago * body mass index of 27-45 kg/m² Exclusion Criteria: * mobility restriction * use of mobility aids * insulin therapy * HbA1c \>12% * TSH \>10 mU/L * heart failure (NYHA III, NYHA IV) * use of obesity pharmacotherapy (orlistat, GLP-1 receptor agonists, GLP-1/GIP dual agonists) for less than 6 months * weight loss greater than 5 kg in the last 6 months * chronic kidney disease and estimated glomerular filtration rate \<30 ml/min/1.73 m2 * active treatment of proliferative diabetic retinopathy with anti-VEGF * heart attack or stroke in the past 1 year * active malignant disease diagnosed in the past 1 year * eating disorders * pregnancy or pregnancy planning * substance abuse * learning disabilities * acute episode of severe depression * current use of antipsychotics * food allergy
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07017127